Eli Lilly is reportedly ignoring a California law which requires drugmakers to both announce and justify prescription drug price hikes months in advance, according to a Los Angeles Times report.
The company says it’s waiting for a court decision on an industry lawsuit challenging the constitutionality of the state’s reporting law.
Sen. Ed Hernandez, the Democratic author of the bill, took issue with the company’s recent request for state lawmakers to help publicize a helpline for patients struggling to buy insulin.
“I should promote my constituents a company that’s breaking the law and raising prices?” Hernandez told California Healthline. “Insulin has been around for decades and there hasn’t been any new innovation. Why not just lower the price so we can all afford it?”
The drugmaker, according to the report, did not respond to the letter, nor to Kaiser Health News’ request for comment.
Click here to read the full report on the Los Angeles Times.
